Sunshine could chill CME attendance

Share this article:

A physician survey by the pro-commercial CME group CME Coalition found that docs are reconsidering their participation in industry-sponsored CME, fearful that their inclusion in Sunshine Act databases as having received payments from companies will fuel perceptions of conflicts of interest.

Asked if “attendance at a commercially-supported CME event was reported in a public, online government database as a ‘payment' from the corporate supporter, would this affect your decision to attend CME courses?” three quarters of respondents said it would affect them at least “Somewhat,” and 47% answered “To a great extent.”

The CME Coalition polled 515 physicians across the US. Ninety-four percent of them had attended certified CME events in the past year. Over half had attended four or more events.

The Sunshine Act was folded into the Affordable Care Act, which passed in March 2010. The Sunshine Act portions of the law are not yet in effect, as the Centers for Medicare & Medicaid Services (CMS) has put off nailing down the details. These delays were the subject of a roundtable convened by one of the Sunshine Act's authors, Senate Committee on Aging chairman Herb Kohl (D-WI), in which CMS was harangued for putting the law on the back burner.

“All of the stakeholders—consumer and industry groups together—want a fair rule and want it implemented now,” Sen. Kohl said in a statement.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?